Collaborating with govt agencies to develop treatment for COVID-19: Cipla
August 05, 2020 15:33 ISTBesides scaling up production of medicines that show potency against the virus -- Lopinavir + Ritonavir, Hydroxychloroquine and Azithromycin, the company is also ramping up manufacturing of drugs for chronic ailments such as asthma, COPD, among others, Hamied said.